07/01/2025 9:27 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/24/2025 2:03 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2025 7:39 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/31/2025 7:33 AM | Trinity Biotech (Filer)
| Form 424B3 | |
03/30/2025 11:15 PM | Trinity Biotech (Filer)
| Form EFFECT | |
03/25/2025 5:29 PM | PERCEPTIVE ADVISORS LLC (Filed by) Trinity Biotech (Subject)
| Form SCHEDULE 13D/A | |
03/21/2025 4:00 PM | Trinity Biotech (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
03/14/2025 3:30 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2025 6:30 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2025 7:30 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/06/2025 8:00 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for TRIB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter.
|
02/04/2025 7:36 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/29/2025 4:15 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/28/2025 10:33 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2024 3:14 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2024 3:05 PM | Trinity Biotech (Filer)
| Form 424B5 | |
12/26/2024 5:19 PM | New Main Equity Co., Ltd. (Filed by) Trinity Biotech (Subject)
| Form SCHEDULE 13D | |
12/26/2024 6:12 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/19/2024 8:55 PM | MiCo IVD Holdings, LLC (Filed by) Trinity Biotech (Subject)
| Form SCHEDULE 13D/A | |
12/18/2024 11:02 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/17/2024 3:42 PM | Trinity Biotech (Filer)
| Form 424B5 | |
12/05/2024 3:30 PM | Trinity Biotech (Filer)
| Form 424B3 | |
12/02/2024 11:15 PM | Trinity Biotech (Filer)
| Form EFFECT | |
11/29/2024 3:45 PM | Trinity Biotech (Filer)
| Form F-3/A | |
11/15/2024 4:00 PM | Trinity Biotech (Filer)
| Form F-3 Registration statement for securities of certain foreign private issuers | |
11/15/2024 12:22 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/14/2024 4:26 PM | PERCEPTIVE ADVISORS LLC (Filed by) Trinity Biotech (Subject)
| Form SC 13D/A | |
11/07/2024 11:33 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/25/2024 12:23 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/25/2024 12:24 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/07/2024 9:35 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/02/2024 10:22 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024 2:07 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2024 5:01 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024 7:11 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2024 4:14 PM | Trinity Biotech (Filer)
| Form 424B5 | |
09/10/2024 9:35 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2024 12:26 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2024 9:52 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/04/2024 10:59 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/29/2024 5:01 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
A new rule goes live in July — and the banks are quietly cashing in (Ad) A little-known regulation quietly goes into effect this July.
And it's already being exploited by Wall Street and the Big Banks…
It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash.
Not stocks. Not real estate. And definitely not the U.S. dollar.
We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them. To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how |
08/27/2024 11:33 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/21/2024 3:40 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/20/2024 12:52 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2024 4:26 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2024 4:27 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2024 4:03 PM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2024 3:53 PM | Trinity Biotech (Filer)
| Form 424B5 | |
07/11/2024 5:55 AM | Trinity Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |